Philip Okala has served as a director of the Company since February 22, 2021. He currently serves as system president at City of Hope, one of the largest cancer research and treatment organizations in the United States, where he is responsible for City of Hope’s portfolio of clinical care and research entities. Mr. Okala was previously the Chief Operating Officer (COO) of the University of Pennsylvania Health System, a network of leading hospitals and associated care facilities serving Philadelphia County and the surrounding area. Prior to his COO role, Mr. Okala held various positions with Penn Medicine since 2007, including serving as Senior Vice President for Strategy and Business Development from 2013 to 2017. Before joining Penn Medicine, Mr. Okala held various positions with other healthcare organizations including System Vice President of the Cancer Service Line at Geisinger Health System, Vice President for Clinical Strategic Planning at Roswell Park Cancer Institute and management positions at the University of Texas MD Anderson Cancer Center. He is a Fellow in the American College of Healthcare Executives (FACHE), a Fellow with Healthcare Financial Management Association, and currently serves on the board of the Holy Child School at Rosemont.